Register to chat with like-minded investors on our interactive forums.
The current AINMF market cap is 72.74M. The company's latest EPS is CAD -0.0461 and P/E is -21.91.
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 113k | 89k | 456k |
| Operating Income | -293k | -3.66M | -10.94M | -12.06M | -3.47M |
| Net Income | -292k | -5.08M | -13.45M | -14.17M | -3.33M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.97M | 8.4M | 9.2M | 1.91M | 207k |
| Total Liabilities | 143k | 458k | 1.09M | 824k | 406k |
| Total Equity | 1.83M | 7.94M | 8.11M | 1.09M | -199k |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -150k | -4.23M | -4.78M | -2.39M | -2.29M |
| Investing | N/A | N/A | -2.19M | N/A | N/A |
| Financing | 1.99M | 8.67M | 691k | 4.16M | 573k |
| Market Cap | 72.74M |
| Price to Earnings Ratio | -21.91 |
| Price to Sales Ratio | 160.32 |
| Price to Cash Ratio | 1.26k |
| Price to Book Ratio | -366.76 |
| Dividend Yield | - |
| Shares Outstanding | 72.26M |
| Average Volume (1 week) | 3.91k |
| Average Volume (1 Month) | 12.52k |
| 52 Week Change | 357.55% |
| 52 Week High | 1.25 |
| 52 Week Low | 0.114 |
| Spread (Intraday) | 1.26 (61.17%) |
| Company Name | Netramark Holdings Inc (QB) |
| Address |
500 burrard street, suite 2900 vancouver, british columbia V6C 0A3 |
| Website | https://www.netramark.com/ |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
